文献速递瓣膜外科

经导管主动脉瓣置换术使用比例对主动脉瓣疾病结局的影响

Impact of transcatheter aortic valve replacement use ratio on outcomes in patients with aortic valve disease.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-11-07

该研究基于美国国家再入院数据库2016至2020年数据,按医院TAVR/AVR比值四分位分组,分析其对TAVR、SAVR及整体AVR结局的影响。结果显示,平衡比例中心的整体AVR死亡率低于低比例中心(1.9% vs 2.1%,P=.01),并发症率低于高比例中心(34.8% vs 36.8%,P<.001)。结论支持平衡的心脏团队以优化AVR结局。

要点

  • 平衡TAVR比例中心的整体AVR死亡率和并发症率优于低或高比例中心。
  • 平衡比例中心TAVR并发症率低于低比例中心(37.3% vs 39%,P<.001)。
  • 平衡比例中心SAVR死亡率和并发症率均低于高比例中心。

核心结论

  • 平衡TAVR比例的医院在TAVR、SAVR及整体AVR结局上优于低或高比例医院。

研究设计与样本

  • 回顾性队列分析,纳入国家再入院数据库2016至2020年采样的所有TAVR和SAVR病例,按医院TAVR/AVR比值四分位分为低、平衡和高比例中心。

主要发现

  • 整体AVR:平衡比例中心死亡率低于低比例中心(1.9% vs 2.1%,P=.01),并发症率低于高比例中心(34.8% vs 36.8%,P<.001)。
  • TAVR:平衡比例中心并发症率低于低比例中心(37.3% vs 39%,P<.001)。
  • SAVR:平衡比例中心术后死亡率低于高比例中心(2.1% vs 2.6%,P<.001),并发症率低于高比例中心(28.6% vs 30.3%,P<.001)。

临床怎么用

  • 支持采用平衡的心脏团队模式以优化主动脉瓣置换的整体结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Use of the Heart Team has been the standard of care for the treatment of aortic valve disease; however, its efficacy has not been evaluated. We sought to analyze its impact using the transcatheter aortic valve replacement (TAVR) use ratio (number of TAVR/total aortic valve replacement [AVR] volume) on TAVR, surgical aortic valve replacement (SAVR), and overall AVR outcomes. METHODS: We analyzed all TAVRs and SAVRs sampled by the National Readmissions Database between 2016 and 2020. Hospitals were stratified into quartiles on the basis of their TAVR/AVR ratio. Centers with a ratio below the first quartile were considered "low ratio," centers in the second and the third quartile "balanced ratio," and centers above the third quartile "high ratio." Primary outcomes were 30-day mortality and complication rate, which included stroke, renal failure, heart block, pacemaker placement, and valve regurgitation. RESULTS: For overall AVR outcomes, centers with a balanced ratio had lower mortality compared with centers with low ratio (1.9% vs 2.1%, P = .01) and lower complication rate compared with centers with high ratio (34.8% vs 36.8%, P < .001). Centers with a balanced ratio had lower TAVR complication rate compared with centers with low ratio (37.3% vs 39%, P < .001). For SAVR outcome, centers with an balanced ratio had lower post-SAVR mortality (2.1% vs 2.6%, P < .001) and complication rate (28.6% vs 30.3%, P < .001) than centers with high ratio. CONCLUSIONS: Centers with balanced TAVR ratios had superior outcomes compared with centers with low or high ratios. These data support the use of a balanced Heart Team to optimize AVR outcomes.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Marghitu T, Roberts SH, He J, et al. Impact of transcatheter aortic valve replacement use ratio on outcomes in patients with aortic valve disease. J Thorac Cardiovasc Surg. 2024. PMID: 39521370. doi:10.1016/j.jtcvs.2024.10.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。